60 Degrees Pharmaceuticals, Inc. (SXTP) News
Track canonical SquawkNews coverage tagged to SXTP, 60 Degrees Pharmaceuticals, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
60 Degrees Pharmaceuticals Announces Private Placement
60 Degrees Pharmaceuticals announces private placement
EQUITY | Jul 30, 2026, 06:26 PM UTC
L
60 Degrees Pharma's B-Free Babesiosis Trial Clears Initial Safety Review, Advances After DSMB Recommendation
60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP, SXTPW))) ("60 Degrees Pharma" or the "Company"), a pharmaceutical company focused on developing new medicines for vector-borne disease, announced today that the independent
REGULATION | Jul 01, 2026, 12:08 PM UTC